EHMT1 Antikörper
(2 Referenzen)Kurzübersicht für EHMT1 Antikörper (ABIN969480)
Target
Alle EHMT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- GLP Antibody
-
Aufreinigung
- Ascitic fluid
-
Immunogen
- Purified recombinant fragment of GLP expressed in E. Coli.
-
Isotyp
- IgG1
-
-
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 1-100) antibody
EHMT1 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 3G1 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) antibodyEHMT1 Reaktivität: Human, Maus, Ratte WB, IF (p), IHC (p) Wirt: Maus Monoclonal 1G9 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) antibodyEHMT1 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 1-260) antibodyEHMT1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 1145-1174), (C-Term) antibodyEHMT1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB13019 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 367-396) antibodyEHMT1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB12579 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 203-233), (N-Term) antibodyEHMT1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB13017 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 979-1010) antibodyEHMT1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB5751 unconjugated
anti-Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1) (AA 1-100) antibodyEHMT1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
-
-
Applikationshinweise
- ELISA: 1/10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus." in: The international journal of biochemistry & cell biology, Vol. 38, Issue 5-6, pp. 845-59, (2006) (PubMed).
: "Inhibition of glucagon secretion." in: Advances in pharmacology (San Diego, Calif.), Vol. 52, pp. 151-71, (2006) (PubMed).
-
: "Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus." in: The international journal of biochemistry & cell biology, Vol. 38, Issue 5-6, pp. 845-59, (2006) (PubMed).
-
- EHMT1 (Euchromatic Histone-Lysine N-Methyltransferase 1 (EHMT1))
-
Andere Bezeichnung
- GLP
-
Hintergrund
- Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from enteroendocrine L cells in response to ingested nutrients. The closely related peptides glucagon-like peptide (GLP-1) and glucagon have opposing effects on blood glucose. GLP-1 induces glucose-dependent insulin secretion in the pancreas, while glucagon stimulates gluconeogenesis and glycogenolysis in the liver. Glucagon is processed from a large precursor, proglucagon, in a tissue-specific manner in pancreatic alpha-cells. The identification of a hybrid peptide acting as both a GLP-1 agonist and a glucagon antagonist would provide a novel approach for the treatment of type 2 diabetes.
-
Gen-ID
- 79813
-
UniProt
- Q9H9B1
Target
-
